Marc Sutton
Partner
London, UK
Articles edited by Marc Sutton
- Excitement and Anticipation as PTC’s Huntington’s Disease Drug Clears a Major Hurdle to Sprint Home
- Do Antidepressants Affect Cognitive Decline? There's More To The Story For Huntington's Disease
- Huntington’s Disease Heroes: A Gratitude Day Feature on Factor-H
- Huntington's Disease Therapeutics Conference 2025 – Day 3
- Huntington's Disease Therapeutics Conference 2025 – Day 2
- Spotting HD Early: The Clues Hidden in Young Brains
- Moving into the Fast Lane: uniQure and the FDA Are on the Same Track for Accelerated Approval
- Self-determination on the HD journey: the role of Advanced Care Planning
- Hope vs. hype: seeking truth in recent Prilenia headlines
- Hereditary Disease Foundation (HDF) conference 2024 – Day 4
- Hereditary Disease Foundation (HDF) conference 2024 – Day 3
- Hereditary Disease Foundation (HDF) conference 2024 – Day 2
- A new era for HDBuzz
- Understanding expansions at the single cell level
- Huntington's Disease Therapeutics Conference 2024 – Day 3
- Huntington's Disease Therapeutics Conference 2024 – Day 2
- Huntington's Disease Therapeutics Conference 2024 – Day 1
- Putting it in print: GENERATION HD1 study results published
- Beyond huntingtin lowering: out-of-the-box approaches for the treatment of HD
- Uncovering the dark side of DNA repair to design HD treatments
- Making babies: having a family, the HD way
Articles written by Marc Sutton
- Full Steam Ahead: uniQure’s On Track With Hope for Accelerated Approval of Huntington’s Disease Drug
- Roche provides an update on tominersen: What’s next for this huntingtin-lowering drug?
- Huntington’s Disease Heroes: A Gratitude Day Feature on Factor-H
- Huntington's Disease Therapeutics Conference 2025 – Day 3
- Huntington's Disease Therapeutics Conference 2025 – Day 2
- Huntington's Disease Therapeutics Conference 2025 – Day 1
- Moving into the Fast Lane: uniQure and the FDA Are on the Same Track for Accelerated Approval
- Huntington Study Group (HSG) Conference 2024 – Day 3
- Huntington Study Group (HSG) Conference 2024 – Day 2
- Huntington Study Group (HSG) Conference 2024 – Day 1
- Hereditary Disease Foundation (HDF) conference 2024 – Day 4
- Hereditary Disease Foundation (HDF) conference 2024 – Day 3
- Hereditary Disease Foundation (HDF) conference 2024 – Day 2
- Hereditary Disease Foundation (HDF) conference 2024 – Day 1
- A new era for HDBuzz
- Huntington's Disease Therapeutics Conference 2024 – Day 3
- Huntington's Disease Therapeutics Conference 2024 – Day 2
- Huntington's Disease Therapeutics Conference 2024 – Day 1
- Putting it in print: GENERATION HD1 study results published
- Drug to treat movement symptoms of HD approved by FDA
- Updates from PTC Therapeutics and uniQure on their huntingtin-lowering trials
- Huntington’s disease therapeutics conference 2023 – Day 3
- Huntington’s disease therapeutics conference 2023 – Day 2
- Huntington’s disease therapeutics conference 2023 – Day 1
- Hunting for balance: how the huntingtin protein compensates in HD
- Update on the PTC Therapeutics PIVOT-HD Trial
- Forward momentum for Roche and Wave in latest news about huntingtin-lowering trials
- Hereditary Disease Foundation (HDF) conference 2022 – Day 4
- Hereditary Disease Foundation (HDF) conference 2022 – Day 3
- Hereditary Disease Foundation (HDF) conference 2022 – Day 2
- Hereditary Disease Foundation (HDF) conference 2022 – Day 1
- Serious side effects reported for some people treated with the huntingtin-lowering drug AMT-130, currently in clinical trials
- Updates from uniQure about their gene therapy for Huntington's disease
- Revisiting vitamin therapy for HD
- Huntington’s disease therapeutics conference 2022 – Day 3
- Huntington’s disease therapeutics conference 2022 – Day 2
- Huntington’s disease therapeutics conference 2022 – Day 1
- Oral drug may change the story for huntingtin lowering
- Finding the silver lining: an update on the Roche GENERATION-HD1 trial data
- Real talk: Q&A with Roche about GENERATION-HD1
- Unpacking recent gene therapy press
- Huntington's disease therapeutics conference 2021 – Day 3
- Huntington’s disease therapeutics conference 2021 – Day 1
- Huntington's disease therapeutics conference 2021 – Day 2
- Disappointing Results from Wave’s PRECISION-HD1 and 2 Trials
- Sad News from Roche and Ionis – ASO Trial Halted Early
- Vaccines and HD
- Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus – Day 2
- When genes are unstable: targeting somatic instability in HD
- Fountain of youth: HTT protein repairs neurons by maintaining youthful state
- What does COVID-19 mean for Huntington’s disease families and HD research?
- Huntington’s disease therapeutics conference 2020 – Day 3
- Huntington’s disease therapeutics conference 2020 – Day 2
- Huntington’s disease therapeutics conference 2020 – Day 1
- Huntington's disease therapeutics conference 2019 – Day 3
- Huntington's disease therapeutics conference 2019 – Day 2
- HDBuzz primer: Clinical trial designs and phases
- Start here!
- Making babies: having a family, the HD way
Articles translated by Marc Sutton
Español
- Mayo de 2025: Este mes en la investigación de la enfermedad de Huntington
- Revisión de la terapia vitamínica para la EH
한국어
فارسی
Deutsch
- Mai 2025: Dieser Monat in der Forschung zur Huntington-Krankheit
- Unlocking the Mind’s Eye: Wie die Huntington-Krankheit die Art und Weise verändert, wie wir die Welt sehen und verarbeiten
- Ein fehlerhafter Filter? Blutgefäßveränderungen bei der Huntington-Krankheit
- Impfungen und die Huntington-Krankheit
- Huntington's Disease Therapeutics Conference 2019 – Tag 1
- Die Vorteile der (Zell)Migration, hervorgehoben am Beispiel der Huntington Krankheit
- Huntingtin schnappt sich den Hammer: Reparatur der DNA in der HK
- Sorry Leute, aber die PRIDE-HD-Studie zeigte NICHT, dass Pridopidin den Verlauf der Huntingon-Krankheit verlangsamt
- Huntingtin macht einen Ausflug: schädliche Proteine verbreiten sich in Hirnzellen
- Gemeinsam Bäume pflanzen: Die Konferenz der Huntington's Disease Society of America 2016
- Deutetrabenazin für Huntington: positive Studienergebnisse aber die FDA sagt nein? Nicht unbedingt…
Nederlands
- Mei 2025: Deze maand in onderzoek naar de ziekte van Huntington
- DNA-herstel bij de ziekte van Huntington: Niet op niveau?
- 10 Gouden Regels voor het Navigeren door Onderzoeksnieuws over de ziekte van Huntington
- Wakker worden: Slaap wordt beïnvloed voordat symptomen van de ziekte van Huntington verschijnen
- Terugblik op 2024
- Bètablokkers geassocieerd met vertraagd begin en verminderde progressie van de ziekte van Huntington
- Zouden spierproblemen het inzicht in bewegingen bij de ziekte van Huntington kunnen verbeteren?
- Gen-uitschakelingsmedicijnen veilig bij ALS-patiënten… kom maar op met die menselijke ZvH testen.
Italiano
- Maggio 2025: Questo mese nella ricerca sulla malattia di Huntington
- Riparazione del DNA nella malattia di Huntington: Non è all’altezza?
- La strada si illumina: Un nuovo biomarcatore per la Malattia di Huntington
- Sarà una nuova tecnica a rivoluzionare il test genetico per la Malattia di Huntington?
Português
- maio de 2025: Este Mês na Investigação da Doença de Huntington
- Reparação do ADN na doença de Huntington: Não estás à altura?
- Unlocking the Mind “s Eye: How Huntington” s Disease Changes How We See and Process the World
- Prémio HDBuzz 2024: Competências Sociais – a jóia escondida para melhorar a qualidade de vida das pessoas com doença de Huntington?
- Um novo mapa para seguir a progressão da doença de Huntington
- Fazer bebés: ter uma família à maneira DH
Polski
- Maj 2025: Ten miesiąc w badaniach nad chorobą Huntingtona
- Jak choroba Huntingtona zmienia nasze postrzeganie i przetwarzanie świata?
Русский
- Май 2025 года: Этот месяц в исследованиях болезни Хантингтона
- Восстановление ДНК при болезни Хантингтона: Не на высоте?
- Открывая глаза разума: как болезнь Хантингтона меняет наше восприятие и обработку мира
Français
- Mai 2025 : Ce mois-ci dans la recherche sur la maladie de Huntington
- Unlocking the Mind’s Eye : How Huntington’s Disease Changes How We See and Process the World (Dévoiler l’œil de l’esprit : comment la maladie de Huntington change notre façon de voir et d’appréhender le monde)